Who is sponsoring NCT04301921?

NCT04301921 is sponsored by Prof. Dr. med. Ingo Eitel.

What drugs are being tested in NCT04301921?

Interventions in NCT04301921: Traditional punkcture site and No anticoagulation, Traditional punkcture site and ACT-guided anticoagulation.

What condition does NCT04301921 study?

NCT04301921 studies Patients Undergoing Diagnostic Coronary Angiography.

Is NCT04301921 still recruiting?

NCT04301921 is currently status unknown. Last updated 24 April 2020.

Last reviewed 2020-04-24 · How we verify

NCT04301921: RAPID-1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Strategies to Maintain Radial Artery Patency Following Diagnostic Coronary Angiography - Diagnostic Transradial Coronary Angiography Without Systemic Anticoagulatio

Status unknown NA Last updated 24 April 2020

What this trial tests

NA trial testing Traditional punkcture site and No anticoagulation in Patients Undergoing Diagnostic Coronary Angiography in 400 participants. Status unknown.

Timeline

1 May 2020

Primary endpoint
30 September 2021

30 June 2022

Quick facts

Lead sponsor	Prof. Dr. med. Ingo Eitel
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	400
Start date	1 May 2020
Primary completion	30 September 2021
Estimated completion	30 June 2022

Drugs / interventions tested

Traditional punkcture site and No anticoagulation
Traditional punkcture site and ACT-guided anticoagulation

Conditions studied

Patients Undergoing Diagnostic Coronary Angiography — all drugs for Patients Undergoing Diagnostic Coronary Angiography →

Sponsor

Prof. Dr. med. Ingo Eitel

Who can join

18 and older, any sex, with Patients Undergoing Diagnostic Coronary Angiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate whether omitting systemic anticoagulation during transradial coronary angiography and/or a distal radial access reduce the risk of postprocedural radial artery occlusion

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Distal access and procedural anticoagulation to prevent radial artery occlusion after coronary angiography - the randomised RAPID trial.
Stiermaier T, Grünewälder M, Pätz T, Rawish E, et al · · 2025 · cited 6× · PMID 40191883 · DOI 10.4244/eij-d-24-00846

Verify or expand the search:

Other Prof. Dr. med. Ingo Eitel trials

Trials by the same sponsor.

NCT06804161 — SGLT2 Inhibition for Cardiovascular Endpoint Reduction in Hypertension · Phase 3 · recruiting
NCT06804148 — MYVAL Transcatheter Heart Valve System - Prospective German Multicenter Registry · recruiting
NCT05204212 — Left Atrial Appendage Closure in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic KIDNEY Disease · NA · recruiting
NCT06977139 — Interventional Structural Registry - LuEbeck · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04301921 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prof. Dr. med. Ingo Eitel
Last refreshed: 24 April 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04301921.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing